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The integration of carbon nanotubes (CNTs) into organized nanostructures is of great interest for appli-
cations in materials science and biomedicine. In this work we studied the self-assembly of β and γ homo-
logues of diphenylalanine peptides under diﬀerent solvent and pH conditions. We aimed to investigate the
role of peptide backbone in tuning the formation of diﬀerent types of nanostructures alone or in combi-
nation with carbon nanotubes. In spite of having the same side chain, β and γ peptides formed distinc-
tively diﬀerent nanoﬁbers, a clear indication of the role played by the backbone homologation on the
self-assembly. The variation of the pH allowed to transform the nanoﬁbers into spherical structures.
Moreover, the co-assembly of β and γ peptides with carbon nanotubes covalently functionalized with the
same peptide generated unique dendritic assemblies. This comparative study on self-assembly using
diphenylalanine backbone homologues and of the co-assembly with CNT covalent conjugates is the ﬁrst
example exploring the capacity of β and γ peptides to adopt precise nanostructures, particularly in combi-
nation with carbon nanotubes. The dendritic organization obtained by mixing carbon nanotubes and pep-
tides might ﬁnd interesting applications in tissue engineering and neuronal interfacing.
Introduction
In natural systems, biomolecules often assemble spon-
taneously and reversibly through the combination of noncova-
lent interactions to generate highly ordered and functional
nanostructures.1–3 Such biomolecular systems in form of nano-
fibrils, nanospheres and hydrogels have been exceptionally
useful in the field of biomedical applications, including drug
delivery, tissue engineering and biosensors.2,4,5 Among the
diﬀerent types of biomolecules, peptides are extremely attrac-
tive tools due to their chemical properties, structural diversity
and biocompatibility.6,7 Diphenylalanine (FF) – the core reco-
gnition motif of the Alzheimer β-amyloid polypeptide – is con-
sidered one of the simplest and most studied building
block.7,8 The ease of synthesis and modification of this small
peptide facilitated the design of various nanostructures such
as nanotubes,9 nanofibers,10 nanospheres,11 nanovesicles,12
and nanowires.13
The structure and the function of peptides are the resultant
of their amino acid composition. They can be altered by
applying strategic modifications at the level of each amino acid
residues. These modifications may include alterations made
on the backbone or on the side chain of the residues.14,15 The
peptides with such modified parts display enhanced biological
stability toward proteolysis.16,17 Besides this, the use of back-
bone homologated amino acids bearing proteinogenic side
chains has emerged as a successful approach to generate sec-
ondary structural motifs in peptidomimetics, called folda-
mers.14,18,19 The additional methylene groups on the
backbone of the peptide provides several degrees of confor-
mational space resulting in various secondary structures. The
hybrids of phenylalanine dipeptides have shown excellent self-
assembling properties leading to the formation of nano-
spheres and nanotubes.20,21 However, the understanding of
the structural diversity of the assemblies formed by these
hybrid peptides is still limited due to the prevalent use of only
natural residues. Further investigations using exact analogues
of backbone homologated diphenylalanines will allow to
better explore the characteristics of the assemblies originated
by the backbone extensions, alone or in combination with
nanomaterials, and to expand their applications.
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Over the past two decades, carbon nanotubes (CNTs) have
gained enormous attention due to their peculiar chemical,
electrical and mechanical properties and found potential uses
in electronics as well as in biomedical engineering.22,23 In
spite of their unique properties, the major stumbling draw-
back was their solubility in aqueous and non-aqueous media.
In this context, surface functionalization of CNTs with biologi-
cally relevant molecules such as nucleobases or oligonucleo-
tides and peptides allowed to obtain hybrid materials much
easier to manipulate with properties that were exploited for
sensing and biomedical applications.22,24,25 Such nano-
materials could also lead to well-defined structures driven by
hydrogen bonding and π–π interactions.26 Among all conju-
gates, covalent CNT–peptide conjugates have been proved to
be very promising as biosensors and biomedical tools.27–29
However, the field of the self-assembly of CNTs in combination
with amino acids or peptides remains still little explored con-
sidering the wide range of possibilities using all α-amino acid
homologues and mimetics. Extended studies in this direction
would be helpful for obtaining a better understanding on the
interaction between these two classes of molecules.
Herein, we present a study on the self-assembly of the back-
bone-homologated analogues of diphenylalanine motif consti-
tuted by β3(R)Phe and γ4(R)Phe. These amino acids are derived
by homologation of the naturally occurring α(S)Phe. The struc-
tural variations induced by solvent and pH changes in both
peptides have been also explored. Moreover, we studied the
co-assembly of β and γ dipeptides and functionalized CNTs
(f-CNTs). The self-assemblies were analyzed by using comp-
lementary electron microscopy and spectroscopy techniques.
Results and discussion
Self-assembly of β and γ peptides
The N-terminal tert-butyloxycarbonyl (Boc)-protected FF
peptide has been extensively studied and it was found to form
tubular structures in water and spherical assemblies in
ethanol.11 In this regard we have been initially interested to
investigate if these assemblies persist with the increase in the
number of carbon atoms within the backbone of the peptide.
Hence, we selectively choose to synthesize two peptides,
corresponding to Boc-β3(R)Phe-β3(R)Phe-OH (1) and Boc-γ4(R)-
Phe-γ4(R)Phe-OH (2) (Fig. 1). These two peptides are backbone
homologues of Boc-protected diphenylalanine (Boc-α(S)Phe-
α(S)Phe-OH) formed by inserting two and four CH2 groups in
β (1) and γ (2) analogues, respectively.
Taking into consideration the diﬀerent experimental con-
ditions reported for the assembly of Boc-Phe-Phe-OH,11,30 we
started our observations using 1 : 1 proportion ethanol/water
solution (50% ethanol solution). To assemble the peptides 1
and 2, the stock solution of each peptide in 1,1,1,3,3,3-hexa-
fluoro-2-propanol (HFIP) at a concentration of 100 mg mL−1
was diluted by adding 50% ethanol solution yielding the
desired concentrations of peptide (see Experimental section in
ESI†). The vortexed solutions were allowed to self-assemble
over 12 hours.
The peptide self-assembly at diﬀerent concentrations start-
ing from 10 down to 1 mg mL−1 was observed using trans-
mission electron microscopy (TEM). At all concentrations,
both β and γ peptides were found to form huge aggregated
nanofibers (not shown). To gain better insights into the organ-
ization of these fibers, the peptides were observed in more
diluted solutions (25–100 μg mL−1 range). At the concentration
of 25 μg mL−1, peptide 1 was able to form nanofiber bundles
originating from a central nucleating point (Fig. 2a and b).
The diameter of the fibers was measured in the range of 20 to
80 nm, with several microns in length. The nanofibers formed
by peptide 2 (at 40 μg mL−1) were instead shorter, more
compact and aligned in parallel-like arrangement creating a
sort of film (Fig. 2c and d). Highly oriented nanofibers of both
peptides at the same concentrations of TEM were also
observed by atomic force microscopy (AFM) (Fig. 3). The line
profile (Fig. 3b) of peptide 1 shows that the nanofibers formed
by depositing 100 μL solution of the 25 µg mL−1 concentration
Fig. 1 Chemical structures of Boc-β3(R)Phe-β3(R)Phe-OH (1) and Boc-
γ4(R)Phe-γ4(R)Phe-OH (2). The additional methylene groups within the
peptide backbone are highlighted in red.
Fig. 2 TEM images of the assemblies of peptide 1 (at 25 µg mL−1)
(a), (b) and 2 (at 40 µg mL−1) (c), (d). The assembly of both peptides leads
to distinctively diﬀerent ﬁbrillar structures.
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measure about 20 nm in height and 60 nm in width. Further-
more, to assess the stability and the lifetime of these assem-
blies, the peptide solutions were stored at room temperature
for 30 days and their assemblies were found unaltered as
shown by scanning electron microscopic (SEM) analysis
(Fig. S1†), thus revealing their long time stability towards
ageing.
Next, to check the nature of these assemblies in similar
protic solvents and to evaluate the role of water and time
course to form the nanostructures, the dilutions were carried
out in pure methanol from a stock solution of the peptides in
pure methanol (without HFIP). A well-mixed peptide solution
was immediately drop cast and after the solvent evaporation,
the TEM images (Fig. S2†) allowed to observe nanofibers with
almost similar morphology to those obtained in 50% ethanol
solution (Fig. 2). The dendritic assemblies of peptide 1 are
formed almost instantaneously, whereas the assembly of
peptide 2 led to a uniform film rather than to defined nano-
fibers. This indicates that the self-assembled structures were
formed in a very short time with no eﬀects in changing the
type of protic solvent. Then we decided to observe the assem-
bly of both peptides in water. We diluted the peptide stock
solutions in HFIP with distilled water to a concentration of
1 mg mL−1, and allowed the peptides to assemble before
observation by TEM (Fig. S3†). The morphology still remains
nanofibrillar unlike Boc-αPhe-αPhe-OH, for which it was found
that the structure changed from spherical to tubular structures
upon changing the solvent from ethanol to water.11 The obser-
vations of peptides 1 and 2 revealed that our nanostructures
are stable at diﬀerent concentrations and solvents. A recent
study on N-acetyl capped β3 peptide hetero-oligomers reported
that the N-terminal capping was a critical parameter in pro-
moting fiber growth.31 Here, in order to verify this parameter,
both C- and N-terminal free β peptide [β3(R)Phe-β3(R)Phe] was
probed for self-assembly. TEM analysis showed the complete
absence of regular structures (Fig. S4†) supporting the key role
of N-capping in forming the fibers. The highly hygroscopic oily
nature of the free γ peptide [γ4(R)Phe-γ4(R)Phe] prevented us to
conduct the control self-assembly experiments. Further spec-
troscopic observations were then performed to assess in more
details the secondary structure of these systems.
The assembly of respective β and γ peptides 1 and 2
obtained from 50% ethanol solution was analyzed by solid-
state Fourier-transform infrared (FT-IR) spectroscopy.32 The
region 3500–3200 cm−1 is important for assessing N–H stretch-
ing vibrations, which provide hydrogen bonding information
in peptides and proteins.33–35 The region 1800–1500 cm−1 cor-
responds to the stretching band of amide I (CvO stretching)
and the bending peak of amide II (C–N stretching and N–H
bending).33,36 Fig. 4a shows two defined N–H stretching bands
at 3357 and 3324 cm−1 for peptide 1, and a band at 3351 with
a shoulder at 3324 cm−1 for peptide 2, respectively. It is well-
established that the non-hydrogen bonded N–H corresponds
to a higher energy bands, while the lower energy bands are
due to intramolecularly hydrogen bonded N–H.36,37 In this
context, the relatively higher band proportion at 3324 cm−1 of
1 in comparison to 2 may be due to a stronger intramolecular
hydrogen bonding. This could be attributed to the observed
highly ordered fibers in 1.
The amide I peaks at 1656 cm−1 in 1 and at 1645 cm−1 in 2
evidence the presence of helical conformations in both
peptides within the fibers.38 This is in agreement with the
Fig. 3 AFM images of peptides 1 (a) and 2 (c) nanoﬁbers formed from
25 and 40 μg mL−1 solutions, respectively, and corresponding topo-
graphical proﬁles of peptide 1 (b) and 2 (d). (Image Z scale (a) = 30 nm,
(b) = 45.5 nm).
Fig. 4 FT-IR spectra of peptides 1 and 2 in the amide A region (a) and
amide I and amide II regions (b).
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reported C14-helical structures of homooligomeric γ-pep-
tides.39 The lower frequency band at 1645 cm−1 in 2 may be
due to the higher flexibility in the backbone of this peptide
combined to a higher solvent exposure, resulting in diﬀerent
stretching frequency than that of peptide 1.38 The frequency of
amide I bands at ∼1685/1689 cm−1 is generally assigned to the
β-sheet structure, similarly to other polypeptides and protein
secondary structures.33,38 In contrast to this assumption, a
recent study suggests that the band around this frequency may
also originate from the carbamate functionality,40 as it is likely
the case of our Boc-protected peptides. Moreover, it is interest-
ing to bring to the attention the aromatic CvC stretching in
the region 1500–1400 cm−1, which is due to the contribution
of the side chains of the peptides. In Fig. 4b, the peak at
1446 cm−1 in 1 is less intense than that in 2 at 1453 cm−1.
This is likely due to significant π–π interactions in peptide 1.
The diphenylalanine based self-assembled nanostructures
can be modulated by varying the experimental conditions such
as solvents, concentrations, pH and temperature. For example,
in the case of diphenylalanine the reversible transition
between nanotubes and nanovesicles was demonstrated by
adjusting the concentration,41 and from nanospheres to nano-
tubes by changing the solvents from ethanol to water.11 In this
regard, since the peptides 1 and 2 form nanofibers in both
tested solvents (i.e. 50% ethanol and water), we decided to
study the eﬀect of pH.
To probe the influence of pH, 30 μL of 0.1 M HCl solution
was added to the peptide solutions (1 mL) at 25 μg mL−1 of 1
and 40 μg mL−1 of 2 in 50% ethanol. The solutions were care-
fully mixed and allowed to self-assemble overnight. The TEM
analysis revealed the transformation of the fibers into partly
coalesced spherical structures in the case of peptide 1 (Fig. 5a
and S5a†) and led to the disassembly with formation of an
irregular film in the case of peptide 2 (Fig. 5b and S5b†). The
size distribution of the nanospheres of peptide 1 measured
from ∼2000 non-coalesced spheres from TEM images varied
from 25 to 140 nm with an average of ∼95 nm (Fig. S6†). The
coalesced spheres formed here are similar to the microspheres
observed in aromatic tripeptide assemblies42 and metal-
mediated modified Phe–Phe dipeptide-based soft spherical
structures.43 The structural diﬀerences between the spherical
and fibrilar assemblies could be due to π–π interactions43 and
diﬀerence in the hydrogen bond strength as already observed
in the transition between spherical to tubular assemblies.44
The spherical structures of 1 at low pH may be due to stronger
hydrogen bonding that could withstand the pH variation. The
disassembly of 2 at low pH may be due instead to the weaker
hydrogen bonding as observed by FT-IR analysis (Fig. 4a).
Overall, the dendritic fibrillar assembly of beta peptide 1 and
parallel-like arranged nanofibers of gamma peptide 2 were
stable upon changing the solvent systems from alcohol to
water. The parent analogue Boc-Phe-Phe-OH modifies instead
its assembly from spherical to tubular nanostructures upon
changing the solvent system (from ethanol to water).11 The
structural stability of diphenylalanine homologues in diﬀerent
solvents implies that their assembly is driven mostly by π–π
interactions rather than hydrogen bonding. In contrast, the
structures of Boc-Phe-Phe-OH were altered by a simple change
in solvent, accounting for an assembly stabilized by weaker
hydrogen bonding.
Self-assembly of peptide-functionalized carbon nanotubes
In the recent years, we and others have demonstrated the
utility of f-CNTs in diﬀerent domains, covering for example cel-
lular uptake by a wide range of cells,45 formation of catalytic
silver nanoparticles,46 and assembly into precise nano-
structures.47,48 In all these reports the binding aﬃnity between
specific moieties and CNTs played an important role. For
example, adenine covalently functionalized to CNTs was
responsible to trigger the formation of catalytic nanoparticles
with controlled size.46 In another study, uracil covalently con-
jugated to CNTs self-assembled into nanorings.47 In these pre-
vious works, the binding aﬃnity between nucleobases and
CNTs due to aromaticity influenced the formation of diﬀerent
molecular architectures. Similarly, other studies also draw
conclusions that peptides containing aromatic residues
have greater interactions with CNTs.49–52 More recently, the
diphenylalanine nanotubes combined with CNTs were used in
amperometric biosensors to detect NADH and phenol.53,54 In
all these works, the aromatic moiety bound on the surface of
CNTs either through covalent or noncovalent interactions
resulted eﬃcient in dispersing CNTs for various electronic and
biomedical applications. On the basis of all these studies, we
have focused our interest to the investigation of the precise
self-assembled structures generated by combining aromatic
peptides 1 and 2 with CNTs, either modified with the same
peptide or just simply using the CNT precursors.
Based on our long term experience in CNTs, here we
decided to study the CNT–peptide assembly using multi-
walled carbon nanotubes (MWCNTs). Peptide 1 was covalently
conjugated to MWCNTs from both N- and C-terminal parts
(Scheme 1) and peptide 2 from C-terminus. The peptides were
conjugated to CNTs by inserting a diaminotriethylene glycol
(TEG) linker (MWCNT-TEG-NH3
+) to provide a certain
flexibility for the self-assembly of the peptide. The diﬀerent
conjugates were characterized by thermogravimetric analysis
Fig. 5 TEM images after changing the pH by adding 0.1 M HCl. Coa-
lesced nanospheres of peptide 1 (a). Disassembled morphology of the
peptide 2 (b).
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(TGA) and TEM. The loading of the N-free peptide on
MWCNT-TEG-β3(R)Phe-β3(R)Phe-NH2 (3) and MWCNT-TEG-
γ4(R)Phe-γ4(R)Phe-NH2 (5) was 126 μmol g−1 (Fig. S7a†) and
84 μmol g−1 (Fig. S7c†), respectively, while the amount of
C-free peptide on MWCNT-TEG-β3(R)Phe-β3(R)Phe-OH (4) was
57 μmol g−1 (Fig. S7b†).
We first decided to focus our attention on the self-assembly
study of the C-free terminus CNT–peptide conjugate 4. The
stock solution of the CNT–peptide conjugates was directly pre-
pared in 1 : 1 proportion ethanol/water by sonicating for a few
minutes until the dispersion became homogeneous. Then, the
conjugates, diluted with 50% ethanol to a final concentration
of 50 μg mL−1, were allowed to self-assemble overnight. The
supernatant solution analyzed by TEM shows disorganized
structures while there are no changes in the morphology of the
peptide-functionalized CNTs in comparison to the CNT precur-
sors (Fig. S8†). On the basis of these findings, we wanted to
explore the behavior of the N-free CNT–peptide conjugate 3 in
the same conditions. The high resolution scanning electron
microscopy (HR-SEM) and TEM analyses revealed the presence
of big aggregated CNTs forming interesting rope-like mor-
phologies of several hundred microns in length (Fig. S9a and
S10a†). The formation of these aggregates may be attributed to
the strong interaction between the unreacted carboxylic acid
functions of CNTs and the amine functions of the peptide
through strong hydrogen bonding, in addition to the intertube
aromatic interactions of the phenyl groups of the peptide. To
assess this assumption, the solution of conjugate 3 was
protonated by adding 50 μL of 0.1 M HCl solution. The
HR-SEM observation showed that the CNT assembly was
clearly disrupted, likely by breaking the hydrogen bonds fol-
lowing the protonation of the peptide N-terminal amines
(Fig. S9b†). Hence, these morphological diﬀerences observed
for conjugates 3 and 4 could be due to the strong hydrogen
bonding capacity of the terminal NH of the peptide in conju-
gates 3 and the carboxylic groups of CNTs, leading to for-
mation of rope-like structures. Whereas weaker interactions
between the terminal OH of the peptide in conjugates 4 and
CvO of CNTs might not be enough to retain a similar kind of
morphology. To explore further the network properties of the
conjugate 3, we studied its co-assembly with the peptide 1.
Based on previous observations, we decided to use a con-
centration of the peptide 1 at 25 μg mL−1 and 50 μg mL−1 of
conjugate 3 (previously sonicated to obtain a homogeneous
dispersion). We mixed the solutions of CNT–peptide conjugate
and peptide in the ratios 1 : 1, 1 : 2 and 1 : 5, vortexed for one
minute, and allowed to self-assemble overnight. Interestingly,
the TEM observation of the 1 : 5 ratio revealed the presence of
regular dendritic assemblies, where CNTs were at the core of
the ramifications likely nucleating their formation (Fig. 6a).
Intrigued by the behavior of CNT–peptide conjugate 3 and
its co-assembly with β peptide 1, we decided to study the
assembled nanostructures of CNT–peptide conjugate 5 in
similar conditions. The TEM analysis of incubated CNT–
peptide conjugate 5 (50 μg mL−1) showed the formation of
aggregated clusters (Fig. S10b†), morphologically diﬀerent
from that of CNT–peptide conjugate 3. We then co-assembled
the CNT–peptide conjugate 5 and peptide 2 (40 μg mL−1) by
mixing them homogeneously in the ratios 1 : 1, 1 : 3 and 1 : 5.
Surprisingly, the TEM analysis of the 1 : 1 ratio revealed the
complete absence of assembly (Fig. S11†), but the 1 : 5 ratio
displayed the formation of the dendritic structures similar to
Scheme 1 Synthesis of MWCNT–peptide conjugates. (i) (a) Neat (COCl)2; (b) Boc-NH-(CH2CH2O)2-CH2CH2-NH2, dry tetrahydrofuran; (c) 4 N HCl
in dioxane. (ii) (a) Boc-β3(R)Phe-β3(R)Phe-OH, EDC, DIPEA, HOBt; (b) 4 N HCl in dioxane; (c) neutralized with 2 N NaOH. (iii) Succinic anhydride,
DIPEA. (iv) (a) EDC, DIPEA, HOBt, H2N-β3(R)Phe-β3(R)Phe-OMe; (b) alkaline hydrolysis; (c) 1 N HCl. (v) (a) Boc-γ4(R)Phe-γ4(R)Phe-OH, EDC, DIPEA,
HOBt; (b) 4 N HCl in dioxane; (c) neutralized with 2 N NaOH.
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those of the co-assembled peptide 1 and CNT–peptide conju-
gate 3 (Fig. 6b).
These dendritic assemblies are clearly influenced by the
formation of a network between the peptide and the CNT–
peptide conjugate. The CNT conjugates outside the nucleation
point are showing the tendency towards the formation of
fibers (Fig. S12a†). It was then interesting to check whether the
amino group on CNTs without peptide would have similar
kind of interactions leading again to dendritic assembly.
Hence, we examined the co-assembly of peptide 1 with the
MWCNT-TEG-NH2, the precursor of conjugate 3. The TEM ana-
lysis showed no dendritic assembly with varied mix pro-
portions of the peptide 1 and MWCNT-TEG-NH2 (Fig. S13†).
This shows that the peptide conjugated to CNTs is responsible
of forming the dendritic network. Next, in order to check if the
variation of the pH, leading to the formation of the nano-
spheres of 1, has an eﬀect on the dendritic morphology of co-
assembled CNT–peptide conjugates, we mixed the solution of
CNT–peptide conjugate 3 and peptide 1 at 1 : 5 ratio (0.6 mL)
and added 50 μL of 0.1 M HCl. The TEM image shows no den-
dritic assembly but a random distribution of peptide nano-
spheres and dispersed CNT–peptide conjugates. However,
some interactions between the peptide nanospheres and the
CNT–peptide conjugates can be still seen (Fig. S14†).
The known stability of unnatural amino acids and the den-
dritic interactions between the backbone extended peptides and
CNTs, found by our investigations, can open the possibility to
explore their use in electronic and biomedical applications.
Altogether, the observations from the present study suggest that
the peptides containing higher homologues of α-amino acids
with proteinogenic side chains can be the promising building
blocks to design various types of nanostructures.
Conclusions
In summary, we have demonstrated the supramolecular struc-
tural diﬀerences between the backbone homologated β and γ
diphenylalanine analogues. We have found that β peptide Boc-
β3(R)Phe-β3(R)Phe-OH and γ peptide Boc-γ4(R)Phe-γ4(R)Phe-OH
self-assemble to generate fibers of diﬀerent dimensions and
shapes, which undergo morphological changes at acidic pH.
This pH sensitivity of the systems could provide the basis for
developing novel pH sensitive β and γ peptide-based materials
including controlled drug release systems. On the other hand,
we have found that the N- and C-terminally free β peptide
(β3(R)Phe-β3(R)Phe-OH) failed to form any regular structures.
Furthermore, co-assembly of β and γ peptides and CNT–
peptide covalent conjugates have shown an excellent mutual
aﬃnity by forming regular dendritic morphologies. The stable
fibrillar nature of β and γ peptides in water as well as 50%
ethanol suggests the idea to use these systems as scaﬀolds for
designing stable hydrogels.55,56 Future work will focus on
using these self-assembled systems for developing hybrid
hydrogels. Using these peptides and CNTs with suitable modi-
fications it would be possible to incorporate and deliver
therapeutic agents or envisage their use also as support for
neuronal interfacing.
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